The approval marks a significant milestone for the American pharmaceutical company in the field of UC
The company plans to add 1700 beds by FY27 through the organic route
Aurigene.AI is an end-to-end solution for small molecule drug discovery
The average time of dilation lasts three to eight hours
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Operations of Line II was stopped due to a fire incident earlier
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
The pilot plant is focused on scaling up beverage production and will support applications
Subscribe To Our Newsletter & Stay Updated
